Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study
Marie Y. Detrait(Hôpital Civil de Charleroi), Mauricette Michallet(Université Claude Bernard Lyon 1), Valerie Chapel, Adèle Dhuyser(Centre Hospitalier Régional et Universitaire de Nancy), Maud D’Aveni(Centre Hospitalier Régional et Universitaire de Nancy), Cécile Pochon(Université de Lorraine), Stéphane Morisset(Lyon 1 Université), Fiorenza Barraco(Hôpital Lyon Sud), Catherine Rioufol(Lyon 1 Université), Gabrielle Roth Guépin(Centre Hospitalier Régional et Universitaire de Nancy), Sylvie Tarillon, Anne Béatrice Notarantonio(Centre Hospitalier Régional et Universitaire de Nancy), Marie Thérèse Rubio(Hôpital Necker-Enfants Malades), Sabine Cohen(Hospices Civils de Lyon)
Cited by 0
Related Papers
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
|The Lancet Haematology|2016|431
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
|Bone Marrow Transplantation|2015|387
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309